Gene · 28898
IGKV1D-27: immunoglobulin kappa variable 1D-27 (pseudogene)
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IGKV1D-27: immunoglobulin kappa variable 1D-27 (pseudogene). Genes, record 28898. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/28898
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,277
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IGKV1D-27 papers | Newest fiscal year |
|---|---|---|---|
| R01DK018381 | Studies on the structure of basement membranes | 10 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P30CA093373 | Cancer Center Support Grant P30 | 5 | 2025 |
| P30EY013079 | Core Vision Grant | 5 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 4 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
| P60AA011605 | Molecular and Circuit Pathogenesis of Alcohol Use Disorders | 4 | 2025 |
| R01CA167426 | Role of PI3Kgamma in Tumor Progression and Metastasis | 4 | 2025 |
| R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 4 | 2025 |
| ZIAAI000887 | Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis | 4 | 2025 |
1 to 10 of 2,277Source NIH's project files
See all 2,277 nih grantsPapers2,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrin α4 and α9 in trabecular meshwork and Schlemm's canal function: emerging regulators of intraocular pressure homeostasis. | Front Cell Dev Biol | 2026 | 42564195 | PubTator, text mining | PubMed |
| Anisotropic unbinding and location-dependent hovering of a kinesin motor head over microtubule. | Biophys J | 2026 | 42381291 | PubTator, text mining | PubMed |
| The human GABA A receptor α4 subunit variant Ile114Asn linked to epilepsy impairs membrane expression with β3 and δ subunits. | MicroPubl Biol | 2026 | 42359281 | PubTator, text mining | PubMed |
| The human GABAA receptor α4 subunit variant Ile114Asn linked to epilepsy impairs membrane expression with β3 and δ subunits. | bioRxiv | 2026 | 42079155 | PubTator, text mining | PubMed |
| Basement membrane components define the microenvironment of aggregated fibroblasts in the skin and support their aggregation in vitro. | Matrix Biol | 2026 | 42002237 | PubTator, text mining | PubMed |
| The roles and heterogeneity of CD8+ T cells in inflammatory bowel disease: A narrative review of insights from single‑cell transcriptomics (Review). | Int J Mol Med | 2026 | 41860039 | PubTator, text mining | PubMed |
| Gut-Lung Microbiota Axis Shapes the Immune Microenvironment and Immunotherapeutic Response in Lung Cancer. | Int J Biol Sci | 2026 | 41800246 | PubTator, text mining | PubMed |
| Beyond MIDAS: An In Silico Study of a Putative Noncanonical C16 Binding Site in αvβ3 Integrin. | ACS Omega | 2026 | 41799060 | PubTator, text mining | PubMed |
| Beta Integrin Expression Defines Functionally Distinct CD4+ T-Cell Subsets That Are Altered in Ulcerative Colitis. | Gastro Hep Adv | 2026 | 41798893 | PubTator, text mining | PubMed |
| Structural Insights Into the Nuclear Import of Gallid Alphaherpesvirus 1 Large Tegument Protein. | Microbiologyopen | 2026 | 41569631 | PubTator, text mining | PubMed |
1 to 10 of 2,763
See all 2,763 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/28898
GET https://conductscience.org/api/genes/v1/28898/grants?page=2